BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 40798)

  • 1. Effect of beta-adrenergic blockade on haemodynamic responses to dynamic and isometric exercise in angina pectoris.
    Nyberg G
    Eur J Clin Pharmacol; 1979 Jul; 15(6):381-8. PubMed ID: 40798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slow-release metoprolol in angina pectoris. A comparative study of a cardioselective beta-blocking drug, metoprolol, in ordinary and slow-release tablets (Durules) in the treatment of angina pectoris.
    Uusitalo AJ; Keyriläinen O
    Ann Clin Res; 1979 Oct; 11(5):199-204. PubMed ID: 44671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of beta-adrenoreceptor blockers on heart rate and blood pressure in dynamic and isometric exercise.
    Nyberg G
    Drugs; 1976; 11 SUPPL 1():185-95. PubMed ID: 6251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of alprenolol on central hemodynamics and exercise tolerance in patients with angina pectoris.
    Jonsson B; Olsson AG; Orö L
    Cardiology; 1973; 58(3):152-61. PubMed ID: 4149331
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of the cardioselective beta-adrenergic receptor blocking agent metoprolol in angina pectoris. Subacute study with exercise tests.
    Ekelund LG; Olsson AG; Orö L; Rössner S
    Br Heart J; 1976 Feb; 38(2):155-61. PubMed ID: 4080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of a new adrenergic blocking agent (K4423) on exercise tolerance in angina pectoris.
    Libretti A; Gregorini L; Valentini R
    Cardiology; 1973; 58(6):369-75. PubMed ID: 4153721
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris.
    Thadani U; Davidson C; Singleton W; Taylor SH
    Am J Med; 1980 Feb; 68(2):243-50. PubMed ID: 6101934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of selective (beta 1) and nonselective (beta 1 and beta 2) beta-adrenergic blockade on systemic and coronary hemodynamic findings in angina pectoris.
    Prida XE; Feldman RL; Hill JA; Pepine CJ
    Am J Cardiol; 1987 Aug; 60(4):244-8. PubMed ID: 2887101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison between alprenolol in tablet form (Aptin) and in "sustained release" form (Aptin Durules) in angina pectoris].
    Lorentzen F; Jorgensen P; Nielsen E; Nyberg G; Hvidt S
    Ugeskr Laeger; 1973 Jul; 135(27):1431-8. PubMed ID: 4585750
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of single doses of alprenolol and two cardioselective beta-blockers (H 87-07 and H 93-26) on exercise-induced angina pectoris.
    Adolfsson L; Areskog NH; Furberg C; Johnsson G
    Eur J Clin Pharmacol; 1974; 7(2):111-8. PubMed ID: 4152864
    [No Abstract]   [Full Text] [Related]  

  • 11. Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
    Arstila M; Iisalo E; Kallio V
    Ann Clin Res; 1969 May; 1(1):13-21. PubMed ID: 4390794
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta-adrenergic receptor blocking drugs in angina pectoris.
    Prichard BN
    Drugs; 1974; 7(1):55-84. PubMed ID: 4151695
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of alprenolol on hemodynamics in angina pectoris.
    Cullhed I
    Acta Med Scand; 1973 May; 193(5):411-8. PubMed ID: 4717322
    [No Abstract]   [Full Text] [Related]  

  • 14. Exercise tolerance in patients with angina pectoris after pentaerythritol trinitrate and alprenolol studied by two different methods.
    Ekelund LG; Melcher A; Orö L
    Eur J Clin Pharmacol; 1975 Jun; 8(5):309-15. PubMed ID: 786682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris.
    Aström H; Vallin H
    Br Heart J; 1974 Dec; 36(12):1194-1200. PubMed ID: 4155316
    [No Abstract]   [Full Text] [Related]  

  • 16. Haemodynamic effects of different beta blockers in angina pectoris.
    Aström H; Jonsson B
    Scott Med J; 1977 Jan; 22(1):64-8. PubMed ID: 13496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
    Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT
    Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of beta-adrenergic blockade (propranolol) on left ventricular hemodynamics and the electrocardiogram during exercise-induced angina pectoris.
    Dwyer EM; Wiener L; Cox JW
    Circulation; 1968 Aug; 38(2):250-60. PubMed ID: 5666841
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of cedilanid-D and alprenolol in angina pectoris.
    Ekelund LG; Johnsson G; Melcher A; Orö L
    Eur J Clin Pharmacol; 1973 Aug; 6(2):113-8. PubMed ID: 4769694
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of cedilanid-D in combination with metoprolol on exercise tolerance and systolic time intervals in angina pectoris.
    Ekelund LG; Johnsson G; Melcher A; Oro L
    Am J Cardiol; 1976 Mar; 37(4):630-4. PubMed ID: 3961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.